Metformine Hydrochloride Aurobindo

Metformin Hydrochloride, the active ingredient in Metformine Hydrochloride Aurobindo, is a biguanide presented as an oral tablet for oral use. It is used to lower blood glucose in adults with type 2 diabetes and related metabolic conditions.

GNH USA supplies Metformine Hydrochloride Aurobindo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metformine Hydrochloride is indicated for disorders of glucose metabolism and related conditions.

- Type 2 diabetes mellitus: improves glycaemic control by lowering fasting and post‑prandial glucose levels. - Prediabetes (impaired fasting glucose): reduces the risk of progression to overt diabetes. - Gestational diabetes mellitus: helps achieve target glucose levels when insulin therapy is not required or feasible.

Metformine Hydrochloride may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Gastrointestinal upset: nausea, abdominal discomfort, or diarrhoea. - Metallic taste in the mouth. - Mild headache. - Decreased appetite. - Weight loss (often modest).

Serious or Rare Side Effects: - Lactic acidosis: a rare but potentially fatal metabolic disturbance. - Severe hypoglycaemia (usually when combined with other glucose‑lowering agents). - Hepatic dysfunction: elevated liver enzymes. - Skin reactions: rash or urticaria. - Vitamin B12 deficiency with long‑term use.

Before initiating Metformine Hydrochloride, several safety considerations should be reviewed.

- Renal function: assess creatinine clearance; avoid in severe renal impairment. - Hepatic disease: use with caution; monitor liver enzymes. - Cardiovascular status: consider in patients with heart failure. - Alcohol intake: limit, as it may increase risk of lactic acidosis. - Pregnancy and lactation: discuss risks and benefits with the prescriber. - Store at ambient temperature: keep below 25 °C, retain in original container, protect from moisture and direct sunlight.

Metformine Hydrochloride can interact with several medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Iodinated contrast agents: may precipitate acute renal failure; discontinue metformin before and after imaging. - Cimetidine: can increase metformin plasma concentrations. - Certain antiretrovirals (e.g., didanosine): raise risk of lactic acidosis.

Moderate Interactions (Monitor Closely): - Diuretics: may affect renal clearance of metformin. - Beta‑blockers: can mask hypoglycaemia symptoms. - ACE inhibitors or ARBs: monitor renal function when combined. - Alcohol: enhances risk of lactic acidosis.